EyeGate Pharmaceuticals vs PhosPrint
EyeGate Pharmaceuticals vs PhosPrint, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyeGate Pharmaceuticals is on 32/100 and PhosPrint on 53/100.
Where each one leads
EyeGate Pharmaceuticals
- funding raised: $45.5M against $1.0M
PhosPrint
- our overall score: 53/100 against 32/100
At a glance
| Measure | EyeGate Pharmaceuticals | PhosPrint |
|---|---|---|
| What it is | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. | Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, 3D Printing |
| Sells toBusiness model | B2B | B2C | B2B2C | B2G | B2B |
| Offering | Software | hardware | services | marketplace | platform | Hardware |
| Founded | 2000 | 2018 |
| Headquarters | Waltham, United States | Athens, Greece |
| Status | Active | Active |
Size, funding and growth
| Measure | EyeGate Pharmaceuticals | PhosPrint |
|---|---|---|
| Employees | Not published | 10 |
| Total funding | $45.5M | $1.0M |
| Latest round | Debt | Seed |
| LinkedIn followers | Not published | 1,569 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyeGate Pharmaceuticals | PhosPrint |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 32/100 | 53/100 |
| Traction | 38/100 | 40/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 5/100 | 36/100 |
| Quality | 35/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 34/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyeGate Pharmaceuticals | PhosPrint |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Wix |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
EyeGate Pharmaceuticals vs PhosPrint: common questions
Which is better, EyeGate Pharmaceuticals or PhosPrint?
On our 0-100 score PhosPrint rates higher (53/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EyeGate Pharmaceuticals and PhosPrint compare on the numbers?
EyeGate Pharmaceuticals leads on funding raised ($45.5M against $1.0M). PhosPrint leads on our overall score (53/100 against 32/100).
Read the full EyeGate Pharmaceuticals review and pricing or the PhosPrint review and pricing. You can also browse other EyeGate Pharmaceuticals alternatives we track.